Enovix Corporation designs, develops, and manufactures lithium-ion battery cells in the United States and internationally.
FAIL · Does not pass the screen
4.40 USD
At the last full screen 2026-08-04
Screened 2026-08-04 · the tape above runs as of 23:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
Enovix Corporation holds its Markdown at $4.40. The statistical read favours the sellers, held for 8 days.
As held on the ledger · 2026-08-04
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 8 days
Price at the screen
$4.40
Valuation
N/A trailing · -7.69 forward price to earnings
Values screen
FAIL· score 10.0
Beta
2.33
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
33.63%
Below 33%
Interest-bearing debt is 33.6% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
31.63%
Below 33%
Cash held in interest-bearing accounts and securities is 31.6% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades at roughly a 100% discount to our $8.80 fair value, 49.10% revenue growth.
Fair value range in USD, drawn from the 2026-08-04 screen. The gold marker is the market price at the same screen. A 100.0% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Buy. The average target sits +184% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Battery Startup Dreams Collide With Heavy Debt
Picture a startup promising better phone and car batteries while already owing more than its balance sheet can comfortably carry. Enovix shows 49 percent revenue growth yet posts zero profit margins and a minus 71 percent return on equity. The ethical screen flags the debt ratio immediately, which is enough on its own to trigger an avoid.
The forward earnings multiple sits at minus 8.2 times because the business is still losing money. Ten analysts may cluster around a buy rating and a 12 dollar target, but our fair value sits at 9.44 dollars and the debt problem overrides any apparent margin of safety.
High leverage in a capital-intensive battery maker creates real refinancing and dilution risk that growth alone has not yet fixed. This is exactly what the screen is for. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ENVX trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-28Distribution · changed$4.40-6.8%Entry 5
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it buy, with a mean price target of $13.
2026-07-27Markup$4.72-35.2%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 35.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it buy, with a mean price target of $13.
2026-07-18Markup$7.28+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (10 analysts) rates it buy, with a mean price target of $13.
2026-07-03Markup$7.28+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markup$7.28Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
